Parylene-Coated Elastomer Valve for Ophthalmic Dispensing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current devices for packaging and dispensing ophthalmic solutions, particularly those containing analogs of prostaglandin, face issues with stability and sterility, as existing solutions often use preservatives that are aggressive to the eyes and fail to maintain the stability of the prostaglandin composition.

Innovation Solution

A device featuring elastomer valves coated with parylene, which allows for the sterile and clean dispensing of calibrated drops by preventing the entry of outside air while ensuring the product's stability through the use of a dispensing accessory with a first valve that allows product passage without allowing air in when relaxed, and a second valve for air filtration without product leakage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antimicrobial preservative agents are added to ophthalmic solutions, then microbial contamination is prevented, but the solution becomes aggressive to the eyes

Engineering Contradiction:
Improvemicrobial contamination preventionVSAvoideye aggression
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and removes the harmful preservative agents from the ophthalmic solution while maintaining microbial protection through an alternative mechanism (elastomer valve system), thereby eliminating eye aggression while preserving contamination prevention

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The elastomer valve acts as an intermediary barrier that prevents microbial contamination without requiring chemical preservatives, thus protecting the solution while avoiding direct contact between harmful agents and the eye

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If elastomer valves are used in dispensing devices, then sterility is maintained, but prostaglandin analogs become unstable and their concentration decreases

Engineering Contradiction:
Improvesterility maintenanceVSAvoidprostaglandin concentration stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The invention changes the material parameters of the valve by coating elastomer with parylene, creating a new composite structure that maintains the elastomer's sterility function while eliminating the harmful interaction with prostaglandin analogs

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a composite valve structure combining elastomer (for sterility and elasticity) with parylene coating (for chemical inertness), thereby achieving both sterility maintenance and prostaglandin stability

Inventive Principle:
Principle #40Composite materials

3Ease of manufacture

If silicone elastomers are used for valves, then pharmaceutical compatibility is achieved, but product stability is compromised

Engineering Contradiction:
Improvepharmaceutical usage compatibilityVSAvoidproduct stability
Core Design Contradiction:
Ease of manufactureVSStability of the object's composition

Solution Approach 1:

The invention combines silicone elastomer (providing pharmaceutical compatibility and elasticity) with parylene coating (providing chemical stability), creating a composite material that maintains the benefits of silicone while eliminating product degradation

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution ensures the stability and sterility of ophthalmic solutions, particularly those containing prostaglandin analogs, by preventing microbial contamination and maintaining the composition integrity, thereby providing a reliable and effective packaging and dispensing system.

Implementation Method 1

The valve is covered with a layer of parylene... Analyses have shown strong interaction between the analogs of prostaglandin and the components of dispensing devices... strong interaction affected valves made of silicone elastomer... Parylene processing resolves this problem posed by the silicone or fluorosilicone membranes

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

The dispensing accessory comprises a first valve made of elastomer material allowing the product to pass through when the dispensing accessory is stressed without allowing outside air to move in the reverse direction when the dispensing accessory is relaxed

Methodology Applied
Scientific EffectElasticity: Elasticity

Data Source

PatentUS10993835B2Device for packaging and dispensing a substance for ophthalmic use
Publication Date: 2021.05.04 HORUS PHARMA
  • US10993835B2 patent drawing
  • US10993835B2 patent drawing
  • US10993835B2 patent drawing

AI summary

Device for packaging and dispensing drops of a substance for ophthalmic use, generally fluid, semi-fluid or in suspension, emulsion or oily solution including a dispensing accessory with a first valve made of an elastomer material that allows the substance to pass through when the dispensing accessory is stressed, without allowing outside air to pass through in the opposite direction when the dispensing accessory is relaxed, characterized in that the first valve is covered by a layer of Parylene.